Quantum BioPharma Ltd. (CSE: QNTM)

Quantum BioPharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 30, 2023	Dec 30, 2022	Dec 30, 2021	Dec 30, 2020	Dec 30, 2019
Market Capitalization	8	47	40	53	38	56
Market Cap Growth	-84.86%	18.00%	-24.98%	39.98%	-31.53%	-85.77%
Enterprise Value	-2	42	8	4	21	51
Last Close Price	4.21	78.00	67.60	85.80	129.35	462.15
PB Ratio	0.36	2.77	0.97	0.78	0.82	1.18
P/TBV Ratio	0.64	4.54	1.60	1.11	1.31	2.21
Debt / Equity Ratio	0.02	0.03	0.02	0.01	0.01	0.04
Quick Ratio	3.72	2.39	2.22	4.13	3.17	1.10
Current Ratio	3.76	2.43	2.28	5.28	4.82	1.25
Return on Equity (ROE)	-73.84%	-83.91%	-63.07%	-75.05%	-78.40%	-90.13%
Return on Assets (ROA)	-37.73%	-43.02%	-33.82%	-40.20%	-43.79%	-33.42%
Return on Capital (ROIC)	-46.47%	-54.26%	-39.99%	-46.09%	-49.95%	-36.32%
Earnings Yield	-141.56%	-50.03%	-79.79%	-83.66%	-106.26%	-91.13%
FCF Yield	-95.31%	-30.26%	-96.15%	-49.19%	-63.93%	-31.94%
Buyback Yield / Dilution	-31.09%	-2.21%	-10.84%	-190.15%	-70.68%	-19.49%
Total Shareholder Return	-31.09%	-2.21%	-10.84%	-190.15%	-70.68%	-19.49%

Source: S&P Capital IQ. Standard template. Financial Sources.